Literature DB >> 11256975

Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease.

A G Cummins1, F M Thompson, R N Butler, J C Cassidy, D Gillis, M Lorenzetti, E K Southcott, P C Wilson.   

Abstract

It is often difficult to assess small bowel recovery in adults with coeliac disease on a gluten-free diet (GFD). This prospective study compares changes in intestinal permeability with changes in intestinal biopsy at various intervals after commencing a GFD. Intestinal permeability was measured by lactulose/rhamnose absorption from 1 week to 24 months after commencing a GFD. Intestinal morphometry was measured by villus area, crypt length and mitotic count per crypt at diagnosis and after commencing a GFD. Median intestinal permeability values decreased from 0.47 (n = 35) at diagnosis to 0.25 (n = 17) after 1 week and to 0.16 (n = 18) after 2 months of a GFD. Rhamnose absorption improved significantly at an early stage, from 6.6% (untreated) to 15.4% at 3 months of a GFD, whereas the decrease in lactulose permeation took longer: from 3.4% (untreated) to 0.8% after 12 months of a GFD. Mean villus area (n = 29) was reduced to 16% of control values at diagnosis, and improved to a maximum of 48% after 6 months on a GFD, but did not change thereafter. Mean crypt length and mitotic count per crypt were increased by 222% and 356% respectively at diagnosis, and these parameters remained elevated at 172% and 216% above control values after 6 months of a GFD. We conclude that intestinal permeability improves within 2 months after starting a GFD, but that measurable intestinal biopsy improvement requires ingestion of a GFD for at least 3-6 months, and even then remains incomplete.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11256975

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

Review 1.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

2.  Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial.

Authors:  Jaya Benjamin; Govind Makharia; Vineet Ahuja; K D Anand Rajan; Mani Kalaivani; Siddhartha Datta Gupta; Yogendra Kumar Joshi
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

3.  Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet.

Authors:  D R Duerksen; C Wilhelm-Boyles; D M Parry
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 4.  Complications of coeliac disease: are all patients at risk?

Authors:  C J R Goddard; H R Gillett
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

5.  Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.

Authors:  Michael T Bethune; Mónica Crespo-Bosque; Elin Bergseng; Kaushiki Mazumdar; Lara Doyle; Karol Sestak; Ludvig M Sollid; Chaitan Khosla
Journal:  Chem Biol       Date:  2009-08-28

Review 6.  Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity.

Authors:  Elena F Verdu; David Armstrong; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2009-06       Impact factor: 10.864

Review 7.  Small bowel review: Diseases of the small intestine.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.487

8.  Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity.

Authors:  Justin Hollon; Elaine Leonard Puppa; Bruce Greenwald; Eric Goldberg; Anthony Guerrerio; Alessio Fasano
Journal:  Nutrients       Date:  2015-02-27       Impact factor: 5.717

9.  A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn's disease.

Authors:  Hutan Ashrafian; Alex J Thompson; Jonathan Gan; Scarlet Nazarian; Julian Teare; Ara Darzi
Journal:  BMC Gastroenterol       Date:  2022-01-10       Impact factor: 3.067

10.  Type 1 diabetes and hyperthyroidism in a family with celiac disease after exposure to gluten: a rare case report.

Authors:  Azita Ganji; Meysam Moghbeli
Journal:  Clin Diabetes Endocrinol       Date:  2018-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.